Prevalence of metabolic syndrome and serum profile of adipokines (leptin and adiponectin) in children with overweight or obesity

Acta Endocrinologica

Volumn 6, Issue 3, 2010, Pages 343-354

  Valean, C ^a   Ichim, G ^a   Tatar, S A ^a   Samasca, G ^b   Leucuta, A ^a   Nanulescu, M ^a  

^a IULIU HATIEGANU UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^b Emergency Hospital for Children   (Romania)

Author keywords

Adipokines; Children; Leptin; Metabolic syndrome; Obesity

Indexed keywords

EID: 79960387987     PISSN: 18410987     EISSN: None     Source Type: Journal    
DOI: 10.4183/aeb.2010.343     Document Type: Article

References (35)

1. Cruz ML, Weigensberg MJ, Huang TT, Ball G, Shaibi. GQ, Goran MI. The metabolic syndrome in overweight Hispanic youth and the role of insulin sensitivity. J Clin Endocrinol Metab, 2004; 89:108-113
2. Weiss R, Dziura J, Burgert TS, Tamborlane WV, Taksal SEi, Yeckel CW, Allen K, Lopes M, Savoye M., Morrison J, Sherwin RS, Caprio S. Obesity and the metabolic syndrome in children and adolescents. N Engl J Med 2004; 350:2362-2374.
3. Madeira IR, Carvalho CNM, Gazolla FM, Pinto LW, Borges MA, Bordallo MAN. Impact of obesity on metabolic syndrome components and adipokines in prepubertal children. J Pediatr. (Rio J.) 2009;.85 (3): 261-268
4. Ahima RS, Flier JS. Leptin. Annu Rev Physiol. 2000;62:413-437.
5. Loffreda S, Yang SQ, Lin HZ, Karp CL, Brengman ML, Wang DJ, Klein AS, Bulkley GB, Bao C, Noble PW, Lane MD, Diehl AM. Leptin regulates proinflammatory immune responses. FASEB J. 1998;12:57-65.
6. Venner AA, Lyon ME, Doyle-Baker PK. Leptin: a potential biomarker for childhood obesity? Clin Biochem. 2006; 39:1047-1056.
7. Bastard J, Maachi M, Lagathu C, Kim MJ, Caron M, Vidal H, Capeau J, Feve B. Recent advances in the relationship between obesity, inflammation, and insulin resistance. Eur Cytokine Netw. 2006;17(1):4-12.
8. Anand SS, Yi Q, Gerstein H, Lonn E, Jacobs R, Vuksan V, Teo K, Davis B, Montague P, Yusuf S. Relationship of metabolic syndrome and fibrinolytic dysfunction to cardiovascular disease. Circulation 2003; 108:420-425.
9. BMI percentile calculator for child and teen. Available from the site of Centres for Disease Control and Prevention: http://apps.nccd.cdc.gov/dnpabmi; accessed March10th 2010
10. CDC growth charts. Available from the site of Centres for Disease Control and Prevention:http:/www.cdc.gov/nchs/about/major/nhanes/growthcharts/clinical_charts.htm; accesed march 10th 2010
11. Diabetes Trial Unit. HOMA Calculator. Available from: http://www.dtu.ox.ac.uk/ Acessed april 15th 2010.
12. The IDF consensus definition of the metabolic syndrome in children and adolescents, 2007; 1-24. available at http://www.idf.org/webdata/docs/Mets_definition_children.pdf, accesed may 10th 2010
13. Ogden CL, Flegal KM, Carroll MD, Johnson CL. Prevalence and trends in overweight among US children and adolescents, 1999-2000. JAMA 2002;288: 1728-1732.
14. Flegal KM, Carroll MD, Ogden CL, Johnson CL. Prevalence and trends in obesity among US adults, 1999-2000. JAMA 2002;288:1723-1727.
15. Mohammadpour-Ahranjani B, Rashidi A, Karandish M, Eshraghian MR, Kalantri N. Prevalence of overweight and obesity in adolescent Tehrani students, 2000-2001: an epidemic health problem. Public Health Nutri 2004;7:645-648.
16. Ebbeling CB, Pawlak DB, Ludwig DS. Childhood obesity: public health, common sense cure. Lancet 2002;360:473-482.
17. Ji C-Y, Working Group on Obesity in China (WGOC). Report on childhood obesity in China (6): prevalence and trends of overweight and obesity in Chinese urban schoolage children and adolescents, 1985-2000. Biomed Environ Sci 2007;20:1-10.
18. Valean C, Tatar S, Nanulescu M, Leucuta A, Ichim G. Prevalence of obesity and overweight among school children in Cluj-Napoca. Acta Endocrinologica 2009; V(2):213-219.
19. DuBose KD, Stewart EE, Charbonneau SR, Mayo MS, Donnelly JE. Prevalence of the metabolic syndrome in elementary school children. Acta Paediatr 2006; 95:1005-11.
20. Goodman E, Daniels SR, Morrison JA, Huang B, Dolan LM. Contrasting prevalence of and demographic disparities in the World Health Organization and National Cholesterol Education Program Adult Treatment Panel III definitions of metabolic syndrome among adolescents. J Pediatr 2004;145:445-451.
21. Pan Y, Pratt CA. Metabolic syndrome and its association with diet and physical activity in US adolescents. J Am Diet Assoc. 2008;108:276-286. discussion 286.
22. Cook S, Auinger P, Li C, Ford ES. Metabolic syndrome rates in United States adolescents, from the National Health and Nutrition Examination Survey, 1999-2002. J Pediatr. 2008;152:165-170.
23. Caprio S. Definitions and pathophysiology of the metabolic syndrome in obese children and adolescents. Int J Obes (Lond) 2005; 29(Suppl 2): S24-S25.
24. Xydakis AM, Case CC, Jones PH, Hoogeveen RC, Liu MY, Smith E, Nelson KW, Ballantyne CM. Adiponectin, inflamation and expresion of metabolic syndrom in obese individuals. J Clin Endocrinol Metab 2004; 89: 2697-2703.
25. You T, Ryan AS, Niclas B. Metabolic syndrome in obese postmenopausal women: relationship to body composition, visceral fat and inflammation. J Clin Endocrinol Metab 2004; 89:5517-5522.
26. Reaven GM. Role of insulin resistance in humandisease. Diabetes 1988;37:1595-1607
27. Ford ES, Giles WH. A comparison of the prevalence of the metabolic syndrome using two proposed definitions. Diabetes Care 2003;26:575-581.
28. Bao W, Srinivasan SR, Berenson GS. Persistent elevation of plasma insulin levels is associated with increased cardiovascular risk in children and young adults. Circulation 1996;93:54-59.
29. Gilardini L, McTernan PG, Girola A, da Silva NF, Alberti L, Kumar S, Invitti C. Adiponectin is a candidate marker of metabolic syndrome in obese children and adolescents. Atherosclerosis 2006; 189:401-407.
30. Mori Y, Hoshino K, Yokota K, Itoh Y, Tajima N. Role of hypoadiponectinemia in the metabolic syndrome and its association with post-glucose challenge hyper-free fatty acidemia: a study in prediabetic Japanese males. Endocr Rev 2006;29:357-362.
31. Spranger J, Kroke A, Mohlig M, Bergmann MM, Ristow M, Boeing H, Pfeiffer AF. Adiponectin and protection against type 2 diabetes mellitus. Lancet 2003; 361:226-228.
32. Shaibi GQ, Cruz ML, Weigensberg MJ, Toledo-Corral CM, Lane CJ, Kelly LA, Davis JN, Koebnick C, Ventura EE, Roberts CK, Goran MI. Adiponectin Independently Predicts Metabolic Syndrome in Overweight Latino Youth. J Clin Endocrinol Metab 2007;92: 1809-1813.
33. Ford ES, Ajani UA, Mokdad AH. The metabolic syndrome and concentrations of C reactive protein among U.S. youth. Diabetes Care 2005;28:878-881.
34. Valle M, Martos R, Gascón F, Cañete R, Zafra MA, Morales R. Low-grade systemic inflammation, hypoadiponectinemia and a high concentration of leptin are present in very young obese children, and correlate with metabolic syndrome. Diabetes Metab. 2005;31:55-62.
35. Cizmecioglu F, Etiler N, Ergen A, Keser A, Hekim N, Hamzaoglu O, Hatun S. Association of Adiponectin, Resistin and High Sensitive CRP Level with the Metabolic Syndrome in Childhood and Adolescence. Exp Clin Endocrinol Diabetes 2009; 117(10):622-627